Extranodal natural killer/T-cell lymphoma is a rare non-Hodgkin lymphoma that is divided into nasal, non-nasal, and aggressive/leukemia subtypes, according to anatomic origin and clinical manifestations, with each subtype carrying a different prognosis. We present a case of primary cardiac natural killer/T-cell lymphoma with extension to other organs in a 38-year-old man, to highlight the role of imaging in categorizing nasal versus non-nasal types. This distinction has relevant implications for patient care because the non-nasal type has a much lower survival rate.
GowdaRM and KahnIA.Clinical perspectives of primary cardiac lymphoma.Angiology2003;
54: 599–604.
2.
JeudyJKirschJTavoraFet al.
From the radiologic pathology archives: cardiac lymphoma: radiologic-pathologic correlation.Radiographics2012;
32: 1369–1380.
3.
BurkeAJeudyJJrVirmaniR.Cardiac tumours: an update.Heart2008;
94: 117–123.
4.
AuWYWeisenburgerDDIntragumtornchaiTet al.
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.Blood2009;
113: 3931–3937.
5.
WongKFChanJKCheungMM and SoJC.Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.Am J Clin Pathol2001;
115: 266–270.
6.
TseE and KwongYL.The diagnosis and management of NK/T-cell lymphomas.J Hematol Oncol2017;
10: 85.